The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, N.
Right arrow Articles by Teixidó, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, N.
Right arrow Articles by Teixidó, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 168: 5268-5277.
Copyright © 2002 by The American Association of Immunologists

The Chemokine Stromal Cell-Derived Factor-1{alpha} Modulates {alpha}4{beta}7 Integrin-Mediated Lymphocyte Adhesion to Mucosal Addressin Cell Adhesion Molecule-1 and Fibronectin1

Natalia Wright*, Andrés Hidalgo2,*, José Miguel Rodríguez-Frade{dagger}, Silvia F. Soriano{dagger}, Mario Mellado{dagger}, Marisa Parmo-Cabañas*, Michael J. Briskin{ddagger} and Joaquin Teixidó3,*

* Department of Immunology, Centro de Investigaciones Biológicas, and {dagger} Department of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid, Spain; and {ddagger} Millenium Pharmaceuticals, Inc., Cambridge, MA 02139


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The interaction between the integrin {alpha}4{beta}7 and its ligand, mucosal addressin cell adhesion molecule-1, on high endothelial venules represents a key adhesion event during lymphocyte homing to secondary lymphoid tissue. Stromal cell-derived factor-1{alpha} (SDF-1{alpha}) is a chemokine that attracts T and B lymphocytes and has been hypothesized to be involved in lymphocyte homing. In this work we show that {alpha}4{beta}7-mediated adhesion of CD4+ T lymphocytes and the RPMI 8866 cell line to mucosal addressin cell adhesion molecule-1 was up-regulated by SDF-1{alpha} in both static adhesion and cell detachment under shear stress assays. Both naive and memory phenotype CD4+ T cells were targets of SDF-1{alpha}-triggered increased adhesion. In addition, SDF-1{alpha} augmented {alpha}4{beta}7-dependent adhesion of RPMI 8866 cells to connecting segment-1 of fibronectin. While pertussis toxin totally blocked chemotaxis of CD4+ and RPMI 8866 cells to SDF-1{alpha}, enhanced {alpha}4{beta}7-dependent adhesion triggered by this chemokine was partially inhibited, indicating the participation of G{alpha}i-dependent as well as G{alpha}i-independent signaling. Accordingly, we show that SDF-1{alpha} induced a rapid and transient association between its receptor CXCR4 and G{alpha}i, whereas association of pertussis toxin-insensitive G{alpha}13 with CXCR4 was slower and of a lesser extent. SDF-1{alpha} also activated the small GTPases RhoA and Rac1, and inhibition of RhoA activation reduced the up-regulation of {alpha}4{beta}7-mediated lymphocyte adhesion in response to SDF-1{alpha}, suggesting that activation of RhoA could play an important role in the enhanced adhesion. These data indicate that up-regulation by SDF-1{alpha} of lymphocyte adhesion mediated by {alpha}4{beta}7 could contribute to lymphocyte homing to secondary lymphoid tissues.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Lymphocytes recirculate from blood to secondary lymphoid tissues and back again into the blood circulation, a process that is of fundamental importance for normal immune surveillance (1, 2, 3). Homing of lymphocytes to lymphoid tissues is mediated by selective interactions between adhesion receptors expressed on lymphocytes and their ligands displayed on high endothelial venules (HEV)4 located on postcapillary venules (4). The integrin {alpha}4{beta}7 is a cell adhesion receptor expressed on different T and B lymphocyte subsets that mediates their attachment to HEV in mucosa-associated lymphoid tissues by interacting with mucosal vascular addressin mucosal addressin cell adhesion molecule-1 (MAdCAM-1) (5, 6, 7, 8, 9). MAdCAM-1, a 60-kDa glycoprotein that belongs to the Ig superfamily, is expressed on HEV in Peyer’s patches, mesenteric lymph nodes, and lamina propria venules within the gut, and its expression represents sites of lymphocyte extravasation into these intestine-associated lymphoid tissues (4, 9, 10). Naive T lymphocytes (CD45RA+ among CD4+) show relatively homogeneous intermediate levels of {alpha}4{beta}7 expression, whereas memory B and T lymphocytes can be subdivided into {alpha}4{beta}7high and {alpha}4{beta}7- populations (6, 11, 12). Both naive and memory T cells home efficiently to Peyer’s patches, but {alpha}4{beta}7- lymphocytes are excluded (12, 13), indicating that {alpha}4{beta}7 expression is associated with homing to intestinal lymphoid tissues.

Apart from mediating cell adhesion to MAdCAM-1, {alpha}4{beta}7 can also interact with the connecting segment-1 region of fibronectin (CS-1/FN) (14, 15). This interaction might play an important role in {alpha}4{beta}7high lymphocyte homing within lymphoid tissues rather than in recruitment of lymphocytes from the blood (4). Several amino acids on both {alpha}4 and {beta}7 subunits that are critical for {alpha}4{beta}7-dependent cell adhesion to MAdCAM-1 and CS-1/FN have recently been identified (16, 17, 18).

After tethering and rolling of lymphocytes on HEV, they rapidly stick and arrest, a process involving {alpha}4{beta}7/MAdCAM-1 interactions and favored by chemokine-triggered integrin activation (19). The stromal cell-derived factor-1{alpha} (SDF-1{alpha}; CXCL12) is a CXC chemokine that potently attracts lymphocytes (20, 21, 22) and exerts chemoattractive and activating functions upon binding to its G protein-coupled receptor CXCR4, which is expressed on B and T lymphocytes, including CD4+ and CD8+ cells (23, 24, 25, 26). In addition, CXCR4 acts as a coreceptor for T-tropic HIV, and SDF-1{alpha} inhibits T tropic HIV infection (23, 25).

Previous studies have shown that SDF-1{alpha} can modulate the adhesive activity of the VLA-4 integrin on CD34+ human bone marrow hemopoietic progenitors, myeloma cells, and T lymphocytes (27, 28, 29, 30). SDF-1{alpha} is constitutively expressed on many tissues, including secondary lymphoid tissues (20, 31), and is therefore a potential candidate to contribute to lymphocyte homing during recirculation. In the present work we have investigated whether {alpha}4{beta}7-dependent lymphocyte adhesion to MAdCAM-1 and CS-1/FN can be subjected to regulation by SDF-1{alpha}. Modulation of this adhesion could contribute to lymphocyte homing to mucosa-associated lymphoid tissue.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cells and Abs

The human B lymphoblastoid cell line RPMI 8866 was cultured in RPMI 1640 medium (BioWhittaker, Verviers, Belgium) supplemented with 10% FBS (BioWhittaker) and antibiotics (complete medium). The Chinese hamster ovary (CHO)-MAdCAM-1 transfectants were maintained in {alpha}-MEM (BioWhittaker) supplemented with 10% FBS and containing 0.8 mg/ml G418 (Calbiochem, San Diego, CA). Human PBMC were isolated from buffy coats using a Ficoll density gradient (Biochrom, Berlin, Germany). After attachment to plastic for 1.5 h at 37°C in complete medium, nonadhered cells were recovered, and CD4+ T lymphocytes were purified with the CD4 Positive Isolation kit (Dynal Biotech, Oslo, Norway). Purity was >99% for each sample, as analyzed by flow cytometry (EPICS XL; Coulter, Hialeah, FL). The mAbs used in this study included anti-{beta}1 Lia 1/2.1, anti-CD4 T4, anti-CD45RA RP 2/2.1, P3X63 (all gifts from Dr. F. Sánchez-Madrid, Hospital de la Princesa, Madrid, Spain), anti-{alpha}4{beta}7 Act-1 (32), anti-CD45RO (Caltag Laboratories, Burlingame, CA), anti-CXCR4 44.717.111 (R&D Systems, London, U.K.), and CXCR4-01 (33). Anti-G{alpha}i polyclonal Ab was purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-G{alpha}13 was a gift from Dr. P. C. Sternweis (University of Texas, Dallas, TX).

Static adhesion assays

The generation of a soluble human MAdCAM-1-Ig fusion protein (sMAdCAM-1-IgG) has been previously described (18). The FN-H89 fragment of fibronectin, which contains the CS-1 site and lacks the RGD central binding domain, was generated as previously reported (34). Cells were labeled for 20 min at 37°C with the fluorescent dye, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) (Molecular Probes, Leiden, The Netherlands), washed, resuspended in adhesion medium (RPMI/0.5% BSA), and preincubated with or without inhibitors or Abs. In those experiments in which soluble recombinant human (rh)SDF-1{alpha} (R&D Systems) was used, cells were incubated with the chemokine and added (6 x 104 RPMI 8866 or 105 CD4+) in triplicate to 96-well dishes (High-binding; Costar, Cambridge, MA) coated with 5 µg/ml FN-H89 as previously described (35) or containing a CHO-MAdCAM-1 monolayer. For adhesions to FN-H89, plates were spun for 15 s to place cells in contact with the ligand and allowed to adhere for 5 min at 37°C. For adhesions to CHO-MAdCAM-1, cells were incubated for 10 min at 37°C with no previous centrifugation. Unbound cells were removed by three washes with RPMI 1640 medium. When rhSDF-1{alpha} was coimmobilized with ligands, the chemokine was prepared at 0.5 µg/ml in sodium bicarbonate buffer (0.1 M, pH 8.8) for FN-H89 (5 µg/ml) or in carbonate buffer (pH 9.5) for sMAdCAM-1-Ig (300 ng/well) adhesions. The mixtures (50 µl/well) were coated on 96-well dishes for 2 h at 37°C, and wells were finally blocked with 0.5% BSA in the same corresponding buffers. For sMAdCAM-1-Ig, cells were allowed to settle for 5 min at 4°C, and then adhesion was conducted for 30 min at 37°C, followed by three gentle washes with RPMI 1640. Bound cells were lysed with 1% SDS in PBS, and the extent of adhesion was quantified using a fluorescence analyzer (POLARstar Galaxy; BMG Labtechnologies, Offenburg, Germany). Inhibitors included cytochalasin D and pertussis toxin (PTX; Calbiochem). Recombinant C3 transferase was expressed and purified as previously described (36).

Flow chamber adhesion assays

Several 15-mm2 areas on petri dishes were coated for 2 h at 37°C with 15 µl PBS containing sMAdCAM-1-IgG alone (4 µg/ml), sMAdCAM-1-IgG with SDF-1{alpha} (2 µg/ml), or SDF-1{alpha} or PBS alone. The coated spots were washed with PBS and blocked for 1 h at 37°C with FCS. Petri dishes were incorporated as the lower wall of a parallel flow chamber (IQUUM, Boston, MA) and mounted on an inverted microscope (IX-70, Olympus, Tokyo, Japan) connected to a CCD camera (Cohu, San Diego, CA). CD4+ or RPMI 8866 cells (106/ml) preincubated in the absence or the presence of PTX and/or anti-{alpha}4{beta}7 Act-1 Ab (10 µg/ml) were infused at 37°C for 2 min at a flow rate of 1 dyne/cm2. Flow was then stopped, and cells were allowed to settle for different times. Total cells from different fields were counted before flow was restored (0.5–2 dyne/cm2), and cells remaining tightly bound for >3 min were counted. Data are presented as the percentage of cells remaining bound compared with total cells in each field before reestablishing the flow.

Actin polymerization and chemotactic assays

To determine the content of polymerized actin (F-actin), 105 cells per condition were permeabilized, fixed, and stained in a single step by addition of a 2x solution containing 0.5 mg/ml L-{alpha}-lysophosphatidyl-choline (Sigma-Aldrich, St. Louis, MO), 8% formaldehyde, and 4 U/ml FITC-phalloidin (Molecular Probes, Eugene, OR). Cells were incubated at 22°C for 10 min, washed with PBS, and subjected to flow cytometry. For chemotactic assays, RPMI 8866 (2 x 105) or CD4+ cells (3 x 105) in 100 µl adhesion medium were placed in the upper chamber of a Transwell (5-µm pore size; Costar). Then 600 µl adhesion medium with or without rhSDF-1{alpha} (200 ng/ml) was added to the lower chamber, and cells were allowed to migrate for 3 h at 37°C. Viable migrated cells were counted in a flow cytometer, analyzing each sample in the same predetermined time and flow conditions. Where indicated, cells were treated with 500 ng/ml PTX for 2 h at 37°C.

GTPase activity assays

We followed essentially the method previously reported (37). The GST-C21 and GST-PAK-CD fusion proteins were generated as previously described (38). To determine the effect of SDF-1{alpha} on RhoA and Rac1 activation, cells were treated with or without 150 ng/ml rhSDF-1{alpha}, washed in ice-cold PBS, and incubated for 15 min at 4°C in lysis buffer (37). For RhoA and Rac1 activation upon {alpha}4{beta}7/sMAdCAM-1-Ig interaction, we performed soluble binding assays of RPMI 8866 cells with sMAdCAM-1-Ig (30–40 µg/ml, 30 min at 23°C), following the method previously described (16). Cells were then collected, washed, and lysed as described above. Lysates were centrifuged, 15 µl was kept for total lysate samples, and the remaining 185 µl was mixed with fusion proteins precoupled to glutathione-agarose beads. The beads and proteins bound to the fusion protein were washed in an excess of lysis buffer, eluted in Laemmli sample buffer, and analyzed for bound Rac1 or RhoA by Western blotting using mAbs against human Rac1 (BD PharMingen/Transduction Laboratories, San Diego, CA) or RhoA (Santa Cruz Biotechnology).

Immunoprecipitation, SDS-PAGE, and Western blot

After SDF-1{alpha} stimulation, untreated or PTX-treated cells were solubilized (20 mM triethanolamine (pH 8), 300 mM NaCl, 2 mM EDTA, 20% glycerol, and 1% digitonin, with 10 µM sodium orthovanadate, 10 µg/ml leupeptin, and 10 µg/ml aprotinin). Following centrifugation, lysates were immunoprecipitated as previously described (39) using CXCR4-01 Ab. Precipitates or protein extracts were separated in SDS-PAGE and transferred to nitrocellulose membranes. Western blot analysis was performed as previously reported (39), using 5% nonfatty dry milk in TBS as the blocking agent. Protein loading was controlled using a protein detection kit (Pierce, Rockford, IL) as well as by reprobing the membrane with the immunoprecipitating Ab.

Statistical analysis

The results are expressed as the mean ± SD of data obtained from three or more experiments performed in triplicate unless otherwise stated. Statistical significance was determined using two-tailed Student’s t test.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
SDF-1{alpha} up-regulates {alpha}4{beta}7-mediated lymphocyte adhesion to MAdCAM-1

Expression of CXCR4 on human CD4+ T lymphocytes and that on the {alpha}4{beta}7+{alpha}4{beta}1- B lymphoblastoid cell line RPMI 8866 have been previously described (24, 26). CXCR4 expression conveyed a chemotactic response of CD4+ and RPMI 8866 cells to SDF-1{alpha} that was abolished by PTX, indicating the participation of heterotrimeric G proteins of the Gi family (Fig. 1GoA). In addition, SDF-1{alpha} triggered a rapid and transient increase in F-actin polymerization in both cell types (Fig. 1GoB). These results indicated that CXCR4 on CD4+ and RPMI 8866 cells mediated cellular responses leading to cell motility and changes in the organization of actin cytoskeleton.



View larger version (13K):
[in this window]
[in a new window]
 
FIGURE 1. SDF-1{alpha} triggers chemotaxis and F-actin polymerization on human CD4+ T lymphocytes and RPMI 8866 cells. A, Cells were preincubated with or without PTX and allowed to migrate in Transwell chemotaxis chambers to medium alone (control) or SDF-1{alpha}-containing lower chambers. Data represent the mean ± SD of two experiments, each performed with duplicate samples. B, Cells were incubated for the indicated times with SDF-1{alpha}, stained with FITC-phalloidin, and subjected to flow cytometry. No change in F-actin content was detected when cells were incubated with medium alone (data not shown).

 
To investigate whether SDF-1{alpha} could influence lymphocyte adhesion to MAdCAM-1, we used CHO transfectant cells expressing MAdCAM-1 on their membranes as well as sMAdCAM-1-IgG. Soluble SDF-1{alpha} transiently up-regulated the adhesion of human CD4+ and RPMI 8866 cells to CHO-MAdCAM-1 transfectants, whereas the anti-{alpha}4{beta}7 Ab Act-1 partially inhibited the increased adhesion (Fig. 2Go), indicating that {alpha}4{beta}7 was involved in SDF-1{alpha}-triggered up-regulation of adhesion and suggesting that additional adhesion pathways were also activated by SDF-1{alpha}. Preincubation of cells with soluble SDF-1{alpha} (from 1 to 20 min) did not significantly influence their subsequent adhesion to sMAdCAM-1-IgG (data not shown). As SDF-1{alpha} can be immobilized and displayed on endothelium (27, 30), we investigated whether SDF-1{alpha} coimmobilized with sMAdCAM-1-IgG could trigger a more effective response in lymphocyte adhesion to this {alpha}4{beta}7 ligand. A robust up-regulation of CD4+ and RPMI 8866 cell adhesion was obtained when both SDF-1{alpha} and sMAdCAM-1-IgG were immobilized on the same well, which was completely blocked by Act-1 Ab (Fig. 3GoA), confirming that SDF-1{alpha}-enhanced adhesion was totally mediated by {alpha}4{beta}7. The extent of increased adhesion was larger when basal adhesion to MAdCAM-1 alone was low. As a control, wells with SDF-1{alpha} alone did not support cell adhesion. In addition, SDF-1{alpha} did not induce CD4+ or RPMI 8866 cell aggregation (data not shown), ruling out a possible contribution to the up-regulated adhesion.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 2. SDF-1{alpha} increases {alpha}4{beta}7-mediated cell adhesion to CHO-MAdCAM-1 transfectants. BCECF-AM-labeled RPMI 8866 or CD4+ T cells were subjected to adhesion for 10 min at 37°C to CHO-MAdCAM-1 monolayers. For 5-min samples, SDF-1{alpha} (200 ng/ml) was added to wells 5 min before the end of adhesion, whereas in the case of 10-min samples SDF-1{alpha} was added from the start of adhesion. For 20-min samples, cells were preincubated with the chemokine for 10 min at 37°C and then added to the adhesion assay. Control samples were subjected to adhesion in the absence of SDF-1{alpha}. Also shown is the adhesion of cells preincubated with anti-{alpha}4{beta}7 Act-1 Ab (10 µg/ml) before the adhesion assay. Adhesions were quantified in a fluorescence analyzer, and data represent the mean ± SD of triplicate samples from one representative result of six (for RPMI 8866) or three (for CD4+) independent experiments. **, Adhesion was significantly stimulated (p < 0.05, by Student’s two-tailed t test).

 


View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 3. SDF-1{alpha} coimmobilized with sMAdCAM-1-IgG up-regulates {alpha}4{beta}7-dependent cell adhesion. A, Static cell adhesion. SDF-1{alpha}, sMAdCAM-1-IgG, or both proteins together were immobilized in adhesion wells as described in Materials and Methods. BCECF-AM-labeled CD4+ T lymphocytes or RPMI 8866 cells were subjected to adhesion for 30 min at 37°C. Some samples were preincubated with anti-{alpha}4{beta}7 Act-1 (10 µg/ml) Ab before the adhesion assay. Adhesions were quantified in a fluorescence analyzer, and data shown are from two independent experiments. Basal adhesion to wells coated with BSA alone is also shown. B, Adhesion under flow conditions. CD4+ or RPMI 8866 cells incubated with or without Act-1 were infused under shear flow over immobilized SDF-1{alpha}, sMAdCAM-1-IgG, or both proteins together. Flow was then stopped, and cells were allowed to settle for 5 min for CD4+ or for 3 min for RPMI 8866 cells. Nonbound cells were washed off with adhesion medium at flow rates of 0.5 or 2 dynes/cm2, as indicated by the numbers in parentheses. Resistance to detachment by shear flow is represented as the mean percentage ± SD (three experiments) of cells remaining bound after 3-min washing from at least four different counted fields compared with the total cells in each field before washing. The percentage of cells remaining bound to FCS is also shown. **, Adhesion was significantly stimulated (p < 0.05, by Student’s two-tailed t test).

 
We next determined whether a brief CD4+ and RPMI 8866 cell exposure to sMAdCAM-1-IgG immobilized with or without SDF-1{alpha} could convey a resistance to detachment under shear stress by measuring the extent of cells remaining bound after applying shear flow. We found that activation with SDF-1{alpha} notably augmented the percentage of CD4+ and RPMI 8866 cells remaining firmly attached to sMAdCAM-1-IgG after applying wall shear stresses of 0.5–2 dynes/cm2 (Fig. 3GoB). Preincubation with Act-1 completely abolished the augmented adhesion, indicating a full involvement of {alpha}4{beta}7, and no cells remained bound to SDF-1{alpha} alone or FCS.

Naive and memory CD4+ T cell subpopulations are both targets for SDF-1{alpha}-triggered up-regulation of adhesion to MAdCAM-1

To determine whether SDF-1{alpha} was preferentially targeting naive CD45RA+ or memory CD45RO+ phenotype cells among human CD4+ T lymphocytes for increased adhesion to MAdCAM-1, we compared by FACS analysis cells recovered from adhesion to MAdCAM-1 alone, MAdCAM-1 coimmobilized with SDF-1{alpha}, or the whole cell population before the adhesion assay. The results showed that the proportions of CD45RA+ and CD45RO+ cells were similar inside the CD4+ cell population attached to MAdCAM-1 immobilized with or without SDF-1{alpha}. However, a minor, but consistent, decrease in naive CD45RA+ cells and a concomitant slight increase in memory cells in the population recovered from adhesions to coimmobilized SDF-1{alpha} and MAdCAM-1 were detected (Fig. 4Go). These data suggest that SDF-1{alpha} targets both memory and naive CD4+ T lymphocytes in the up-regulation of {alpha}4{beta}7-mediated adhesion to MAdCAM-1, with a slight preference for memory CD45RO+ cells.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 4. Expression of CD45RA and CD45RO on CD4+ T cells bound to MAdCAM-1/SDF-1{alpha}. CD4+ T lymphocytes recovered from adhesions to sMAdCAM-1-Ig alone or from sMAdCAM-1-Ig coimmobilized with SDF-1{alpha} or total CD4+ cells before adhesion were analyzed by FACS using anti-CD45RA or anti-CD45RO Abs. The dashed line in each panel represents control staining obtained with the P3X63 Ab. The percentages of cells stained with Abs are indicated. Shown are two results representative of five separate experiments.

 
SDF-1{alpha} increases {alpha}4{beta}7-mediated adhesion to CS-1/fibronectin

The CS-1 region of fibronectin represents an additional binding site for {alpha}4{beta}7 (14, 15). We used RPMI 8866 cells to test the effect of SDF-1{alpha} on adhesion to FN-H89, a CS-1-containing fragment of fibronectin. A short (2-min) incubation of RPMI 8866 cells with soluble SDF-1{alpha} augmented the adhesion to FN-H89, which was blocked by Act-1, but not by Lia 1/2.1 anti-{beta}1 Ab (Fig. 5Go, left panel). Similar to sMAdCAM-1-IgG, a substantially higher up-regulation of adhesion of RPMI 8866 cells was obtained when both FN-H89 and SDF-1{alpha} were coimmobilized in the same well compared with the adhesion to FN-H89 alone (Fig. 5Go, right panel). The adhesion was totally inhibited by Act-1, indicating that {alpha}4{beta}7 was mediating this increased adhesion.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 5. Effect of SDF-1{alpha} on {alpha}4{beta}7-dependent cell adhesion to FN-H89. Left panel, BCECF-AM-labeled RPMI 8866 cells were incubated for 2 min at 37°C in the absence (control) or the presence of SDF-1{alpha} and subjected to adhesion for 5 min at 37°C to FN-H89 after a short spin. Some samples were preincubated with Act-1 anti-{alpha}4{beta}7 or Lia 1/2.1 anti-{beta}1 Abs. Right panel, Labeled cells were directly assayed in adhesion to FN-H89 alone or coimmobilized with SDF-1{alpha}. Also shown is adhesion of cells preincubated with Act-1 before the adhesion assay. Adhesions were quantified in a fluorescence analyzer, and data represent the mean ± SD of triplicate samples from a representative result of six (left panel) or three (right panel) experiments. **, Adhesion was significantly stimulated (p < 0.05, by Student’s two-tailed t test).

 
Effect of PTX on SDF-1{alpha}-triggered increase in {alpha}4{beta}7-mediated cell adhesion

As shown above, chemotaxis of CD4+ and RPMI 8866 cells in response to SDF-1{alpha} was abolished by PTX, an agent that catalyzes the ADP ribosylation of specific G protein {alpha} subunits of the Gi family, preventing receptor-G protein interactions (40). PTX did not reduce the enhancement of static adhesion of CD4+ T cells to MAdCAM-1 coimmobilized with SDF-1{alpha} when a 30-min adhesion time was used or when we performed shorter (7.5-min) adhesions after a spin to place cells in contact with ligands, an assay condition that resulted in similar basal adhesion levels and up-regulated CD4+ adhesion (Fig. 6GoA, left panel). Only a small fraction (<20%) of the increased adhesion of RPMI 8866 cells to MAdCAM-1 immobilized with SDF-1{alpha} was inhibited by PTX when adhesion was conducted for 30 min (Fig. 6GoA, right panel). When we shortened the time of adhesion to 2 min after cell centrifugation, a 40–50% inhibition by PTX was obtained. In addition, the SDF-1{alpha}-triggered increase in RPMI 8866 cell adhesion to FN-H89 was only partially reduced by PTX both when soluble SDF-1{alpha} was used and when it was coimmobilized with FN-H89 (Fig. 6GoB).



View larger version (31K):
[in this window]
[in a new window]
 
FIGURE 6. Effect of PTX on SDF-1{alpha}-triggered up-regulation of {alpha}4{beta}7-dependent cell adhesion under static conditions. BCECF-AM-labeled CD4+ or RPMI 8866 cells were exposed to PTX (500 ng/ml, 2 h) or adhesion medium alone. A, Cells were allowed to adhere for the indicated times to sMAdCAM-1-IgG coimmobilized with SDF-1{alpha}. B, left panel, RPMI 8866 cells were incubated for 2 min in the absence (control) or the presence of SDF-1{alpha} and were subjected to adhesion for 5 min at 37°C to FN-H89 after a short spin. B, right panel. The results when cells were directly assayed for adhesion to FN-H89 coimmobilized with SDF-1{alpha}. Adhesions were quantified in a fluorescence analyzer, and data represent the mean ± SD from at least two independent experiments, each performed with triplicate samples. **, Adhesion was significantly inhibited (p < 0.05 by Student’s two-tailed t test); *, inhibition was observed, but did not reach the p < 0.05 confidence level.

 
When shear stress was applied through PTX-treated CD4+ T lymphocytes settled for 5 min on MAdCAM-1 immobilized with SDF-1{alpha}, the increase in adhesion strengthening measured as cells remaining attached under flow was reduced by about half compared with the adhesion of cells incubated without PTX (Fig. 7Go). As is the case of static adhesion, when the time of cell contact to MAdCAM-1/SDF-1{alpha} was increased for >10 min, no effect of PTX was detected (data not shown). PTX also partially reduced (30–50%) the percentage of RPMI 8866 cells remaining bound to MAdCAM-1 immobilized with SDF-1{alpha} under shear stress after a 3-min adhesion (Fig. 7Go), and this inhibition decreased with longer (5-min) adhesions (data not shown). The Act-1 Ab blocked all adhesions, confirming the full involvement of {alpha}4{beta}7 in these attachments. Together, these results suggest that G{alpha}i-dependent as well as G{alpha}i-independent signaling are involved in SDF-1{alpha}-triggered enhancement of {alpha}4{beta}7-mediated cell adhesion.



View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 7. Resistance to detachment by shear flow of PTX-treated cells attached to MAdCAM-1/SDF-1{alpha}. Cells incubated with or without PTX (500 ng/ml, 2 h) and/or Act-1 anti-{alpha}4{beta}7 Ab were infused through areas coated with the indicated ligands. Flow was stopped, cells were allowed to settle for 5 min for CD4+ or 3 min for RPMI 8866 cells, and flow (0.5 and 1 dynes/cm2, respectively) was restored. Bound cells from at least four different fields were counted after a 3-min washing. Data represent the mean percentage ± SD (three experiments) of cells remaining bound after washing from at least four different counted fields compared with total cells in each field before washing. **, Adhesion was significantly inhibited (p < 0.05, by Student’s two-tailed t test).

 
Role of Rho GTPases and actin cytoskeleton in up-regulation of {alpha}4{beta}7-mediated cell adhesion by SDF-1{alpha}

Small GTPases of the Rho family, like RhoA and Rac1, are key regulators of the organization of actin cytoskeleton (41). Upstream events leading to the exchange of GDP for GTP bound to Rho GTPases activate them so they can then interact with downstream targets to produce different biological responses. We used RPMI 8866 cells to study whether SDF-1{alpha} influences the activation of RhoA and Rac1, by performing pull-down assays with GST fusion proteins containing domains derived from Rho GTPase targets. SDF-1{alpha} rapidly (1 min) and substantially increased the amount of active RhoA and Rac1 from basal levels, as detected with the GST-C21 and GST-PAK-CD fusion proteins, respectively, and this activation was still detected, although at lower levels, after 15-min incubations (Fig. 8GoA). To obtain some insight into a potential participation of RhoA activation in the SDF-1{alpha}-triggered increase in RPMI 8866 adhesion, we used C3 transferase, an enzyme that specifically ADP-ribosylates and inhibits Rho activation (42). C3 reduced to approximately half the increase in RPMI 8866 cell adhesion to MAdCAM-1 immobilized with SDF-1{alpha}, whereas it totally blocked their up-regulated adhesion to FN-H89 (Fig. 8GoB), suggesting that activation of RhoA could be involved in the increased adhesion. Cytochalasin D, an agent that disrupts actin filaments, blocked the up-regulation of F-actin polymerization triggered by SDF-1{alpha} on CD4+ and RPMI 8866 cells (data not shown). Preincubation with cytochalasin D at concentrations of up to 5 µg/ml substantially inhibited the enhanced adhesion of CD4+ T lymphocytes without affecting their basal adhesion to MAdCAM-1 alone (Fig. 8GoC). This same concentration partially inhibited (30%) the increase in adhesion of RPMI 8866 cells, and we did not use higher concentrations because basal adhesion was affected. These results suggest that the actin cytoskeleton plays a relevant role in SDF-1{alpha}-induced enhancement of cell adhesion to MAdCAM-1 mediated by {alpha}4{beta}7.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 8. Role of Rho GTPases and actin cytoskeleton in up-regulation of {alpha}4{beta}7-mediated cell adhesion by SDF-1{alpha}. A, SDF-1{alpha} activates RhoA and Rac1 on RPMI 8866 cells. Cells were treated with SDF-1{alpha} for the stated times and solubilized, and lysates were incubated with glutathione agarose-bound fusion proteins to detect active RhoA and Rac1. Beads and proteins bound to fusion proteins were eluted in Laemmli sample buffer and analyzed for bound RhoA and Rac1 by Western blot using anti-RhoA and anti-Rac1 Abs. Aliquots of the respective lysates served as controls for analyzing the total amounts of RhoA and Rac1. B, Effect of C3 on the up-regulation of {alpha}4{beta}7-dependent cell adhesion by SDF-1{alpha}. RPMI 8866 cells were exposed to C3 (50 µg/ml, 16 h) or adhesion medium alone (control). After labeling with BCECF-AM, cells were allowed to adhere for 30 min at 37°C to sMAdCAM-1-IgG alone or coimmobilized with SDF-1{alpha} (left panel) or were incubated for 2 min with or without SDF-1{alpha} and assayed for 5 min at 37°C in adhesion to FN-H89 (right panel). C, Role of actin cytoskeleton in SDF-1{alpha}-triggered increase in {alpha}4{beta}7-mediated adhesion to MAdCAM-1. BCECF-AM-labeled CD4+ or RPMI 8866 cells were incubated for 30 min at 37°C in adhesion medium alone (control) or with the indicated amounts of cytochalasin D (Cyt D) and allowed to adhere to sMAdCAM-1-IgG alone or coimmobilized with SDF-1{alpha}. Adhesions were quantified in a fluorescence analyzer, and data represent the mean ± SD from at least three independent experiments, each performed with triplicate samples. **, Adhesion was significantly inhibited (p < 0.05, by Student’s two-tailed t test); *, inhibition was observed but did not reach the p < 0.05 confidence level.

 
We also analyzed whether the {alpha}4{beta}7/sMAdCAM-1-IgG interaction itself could trigger additional activation of RhoA and/or Rac1. In a soluble binding assay (16), RPMI 8866 cells bound sMAdCAM-1-IgG, as detected by flow cytometry using a PE-conjugated anti-human IgG Fc-specific Ab, and the Act-1 Ab abolished the binding (data not shown). Pull-down assays performed with GST-PAK-CD and GST-C21 fusion proteins using RPMI 8866 cells incubated with sMAdCAM-1-IgG showed a modest (2-fold) increase in Rac1 activation that was inhibited by blocking {alpha}4{beta}7/sMAdCAM-1-IgG binding with Act-1, whereas no significant alterations in RhoA activation were detected (Fig. 9Go).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 9. Activation of RhoA and Rac1 upon {alpha}4{beta}7/MAdCAM-1 interaction. RPMI 8866 cells were incubated with medium alone (Control) or with soluble sMAdCAM-1-Ig in the presence or the absence of the Act-1 anti-{alpha}4{beta}7 Ab. Cells were solubilized, lysates were incubated with glutathione agarose-bound fusion proteins to detect active RhoA and Rac1, and samples were processed and analyzed as described in Fig. 8Go.

 
SDF-1{alpha} induces association of CXCR4 with heterotrimeric G{alpha}i and G{alpha}13 proteins

Western blot analysis of RPMI 8866 lysates using Abs to several heterotrimeric G{alpha} proteins revealed significant expression of G{alpha}i as well as PTX-resistant G{alpha}13 and G{alpha}q/11 (data not shown). To characterize G protein association with CXCR4 upon SDF-1{alpha} stimulation, we incubated RPMI 8866 cells with SDF-1{alpha}, and cell lysates were immunoprecipitated with anti-CXCR4 Abs, followed by Western blotting using anti-G{alpha}i and G{alpha}13 Abs. The results showed that G{alpha}i rapidly and transiently interacted with CXCR4 upon SDF-1{alpha} activation, with a maximum association detected between 1 and 3 min (Fig. 10Go). G{alpha}13 also associated with CXCR4 after SDF-1{alpha} stimulation, but with slower kinetics (maximum at ~5 min) and to a lesser extent compared with CXCR4/G{alpha}i association, as longer gel exposures were needed to sufficiently detect G{alpha}13. G{alpha}i was barely detected associated with CXCR4 when these experiments were conducted with PTX-treated cells. Interestingly, higher amounts of G{alpha}13 were found associated with CXCR4, and time kinetics revealed a faster CXCR4/G{alpha}13 interaction compared with nontreated RPMI 8866 cells (Fig. 10Go). These data indicate that G{alpha}i and G{alpha}13 are involved in SDF-1{alpha}-induced RPMI 8866 cell activation.



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 10. SDF-1{alpha} induces association of CXCR4 with G{alpha}i and G{alpha}13. Untreated (Control) or PTX-treated (500 ng/ml, 2 h) RPMI 8866 cells were stimulated with SDF-1{alpha} for the indicated times. Cells were solubilized, and lysates were immunoprecipitated with anti-CXCR4–01 Ab and tested in a Western blot with anti-G{alpha}i or G{alpha}13 Ab as indicated. Equivalent receptor loading was controlled by reprobing each membrane with CXCR4–01 Ab. As a positive control, unprecipitated RPMI 8866 cell lysates were tested in a Western blot with G{alpha}i or G{alpha}13 Ab (lysate). A representative experiment of three performed is shown.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In the present study we have investigated the role of SDF-1{alpha} in {alpha}4{beta}7-mediated lymphocyte adhesion using human CD4+ T lymphocytes and the lymphoblastoid cell line RPMI 8866 as models. The results indicated that SDF-1{alpha} strongly up-regulated their {alpha}4{beta}7-dependent adhesion to sMAdCAM-1-Ig as well as their adhesion to membrane-bound MAdCAM-1 expressed on CHO transfectants. In addition, SDF-1{alpha} increased {alpha}4{beta}7-mediated RPMI 8866 cell attachment to the CS-1-containing FN-H89 fragment of fibronectin.

Enhancement of cell adhesion to sMAdCAM-1-Ig was detected by coimmobilizing SDF-1{alpha} with this {alpha}4{beta}7 ligand and was achieved in both static adhesion assays as well as under shear stress by measuring the resistance to cell detachment after applying shear flow. The data suggested that the effect of SDF-1{alpha} on {alpha}4{beta}7-mediated adhesion to sMAdCAM-1 probably involved strengthened cell adhesion to this ligand, leading to firm attachment. The rational for using immobilized SDF-1{alpha} was based on the observation that it can be found attached to bone marrow endothelium (27) and can be displayed on the surface of HUVEC (30). Although we do not have experimental evidence, it is possible that up-regulation of {alpha}4{beta}7-mediated lymphocyte adhesion to CHO-MAdCAM-1 induced by soluble SDF-1{alpha} might be due to its attachment to the surface of CHO-MAdCAM-1 monolayers, which could stabilize its binding to CXCR4 on lymphocytes.

The increase in {alpha}4{beta}7-mediated CD4+ cell adhesion to MAdCAM-1 by SDF-1{alpha} targeted both naive CD45RA+ and memory CD45RO+ subset cells. Memory cells express lower levels of CXCR4 than naive cells (24, 26, 43), but they respond to SDF-1{alpha} with equal or even slightly higher efficacy in up-regulation of adhesion to MAdCAM-1. This could be due to the fact that {alpha}4{beta}7+ memory cells express higher levels of {alpha}4{beta}7 than naive cells (11, 12, 44), which might allow them to attach with more strength to MAdCAM-1, enhancing the likelihood of SDF-1{alpha}/CXCR4 binding. These results suggest that the pattern of {alpha}4{beta}7 expression among memory and naive subset cells and the subsequent {alpha}4{beta}7/MAdCAM-1 interaction might be dominant over the signaling originated upon SDF-1{alpha}/CXCR4 binding, which triggers the increase in cell adhesion.

Chemotaxis of CD4+ and RPMI 8866 cells in response to SDF-1{alpha} was abolished by PTX, indicating an involvement of heterotrimeric G proteins of the Gi family. However, their up-regulated adhesion to sMAdCAM-1-Ig triggered by SDF-1{alpha} was only partially affected by PTX when tested on resistance to cell detachment under shear flow or in static adhesion assays. These data indicate that G{alpha}i-dependent signaling is involved in the subsequent increase in {alpha}4{beta}7 adhesive activity and suggest that additional, G{alpha}i-independent signaling plays a role in SDF-1{alpha}-triggered enhanced adhesion. Reinforcing the involvement of G{alpha}i in the modulation of {alpha}4{beta}7-mediated cell adhesion, we detected a rapid and transient association with CXCR4 in RPMI 8866 cells incubated with SDF-1{alpha}.

PTX-insensitive heterotrimeric G proteins include members of the G12 and Gq families (45). We show in this work that in RPMI 8866 cells SDF-1{alpha} stimulated the interaction of CXCR4 with G{alpha}13, a G{alpha}12 family member, although to a lesser degree and with slower kinetics than CXCR4/G{alpha}i association. Interestingly, the amount of CXCR4-associated G{alpha}13 upon SDF-1{alpha} stimulation was notably enhanced in cells treated with PTX, and, as expected, there was a large reduction in G{alpha}i/CXCR4 interaction, raising the possibility that both G{alpha}i and G{alpha}13 interact with the same or closely located binding sites on CXCR4 and that G{alpha}13/CXCR4 association increases after G{alpha}i blockade. Alternatively, G{alpha}i might influence G{alpha}13 binding at a different site on CXCR4, which again could be increased upon inhibition of G{alpha}i binding. Therefore, the PTX-resistant increase in cell adhesion to MAdCAM-1 in response to SDF-1{alpha} could be the result of enhanced G{alpha}13 activation and its involvement in this adhesion. A known downstream effector target of G{alpha}13 is p115 RhoGEF (46), a Rho-activating guanine nucleotide exchange factor, and it has been reported that activation of G{alpha}13 mimicked the effects of activated forms of Rho on stress fiber formation that was inhibited by C3 (47, 48). In the present work we show that SDF-1{alpha} activated RhoA and Rac1 on RPMI 8866 cells, and inhibition of RhoA activation by C3 considerably reduced the up-regulation of {alpha}4{beta}7-dependent adhesion, suggesting that activation of RhoA represents an important point in the signals leading to increased adhesion. Previous work reported that expression of activated forms of RhoA caused an increase in {alpha}4{beta}7-dependent T lymphoma adhesion to MAdCAM-1 (49), an observation in the same line as the present findings on the proposed role of RhoA activation by SDF-1{alpha} in the up-regulation of {alpha}4{beta}7-mediated cell adhesion.

Additionally, we found that blockade of SDF-1{alpha}-triggered F-actin polymerization in CD4+ and RPMI 8866 cells by cytochalasin D interfered with their response by increased adhesion to MAdCAM-1. As RhoA and Rac1 are key regulators of actin cytoskeleton organization, and their activity influences cell motility (41), it is possible that a functional link exists between SDF-1{alpha}-induced activation of RhoA and Rac1 and reorganization of actin cytoskeleton, which could be associated with the modulation of {alpha}4{beta}7-dependent cell adhesion.

Together these data indicate that G{alpha}i-dependent signaling plays an important role in the up-regulation of {alpha}4{beta}7-dependent cell adhesion to MAdCAM-1 in response to SDF-1{alpha} and raises the possibility that activation of G{alpha}13 could also contribute to the up-regulated adhesion. The kinetics of CXCR4 association with G{alpha}i and G{alpha}13 suggest that the faster signaling wave leading to increased adhesion originates from G{alpha}i activation. Activation of G{alpha}i results in inhibition of adenylyl cyclases (45), and it has been suggested that changes in cAMP levels due to modulation of adenylyl cyclase activity by chemoattractants could represent an important point in the regulation of integrin-dependent leukocyte adhesion (50). Therefore, alterations in cAMP levels by G{alpha}i-activated downstream signaling could also be involved in the SDF-1{alpha}-triggered increase in {alpha}4{beta}7 adhesive activity. Several studies focused on {alpha}4 integrin-mediated adhesion have also determined that Gi-dependent signaling is needed to activate this adhesion, based on PTX inhibition (19, 30, 51, 52). A second signaling wave, G{alpha}I independent and potentially arising from G{alpha}13, could activate downstream effectors, such as RhoA and perhaps also Rac1, which could result in an additional increase in and/or maintenance of {alpha}4{beta}7-mediated adhesion, favoring lymphocyte adhesion strengthening and resistance to detachment under shear stress. Studies addressing G{alpha}i and G{alpha}13 involvement in modulation of {alpha}4{beta}7-dependent lymphocyte adhesion using mutant forms of these G proteins will be of key importance to characterize their participation in this process. In addition, it has been recently reported that SDF-1{alpha} activates Gq, which mediates LFA-1 activation during in vivo migration of T cell hybridoma cells (53). A possible activation of Gq by SDF-1{alpha} in lymphocytes could represent an additional candidate mechanism contributing to the increase in {alpha}4{beta}7 adhesive activity.

Reorganization of actin cytoskeleton induced by SDF-1{alpha} might cluster {alpha}4{beta}7 on the cell membrane, which might influence the avidity for its ligands. In this regard, it has been proposed that integrin clustering plays important roles in changes in the avidity of {alpha}4{beta}1-mediated adhesion (30, 54). Additionally, affinity modulation of {alpha}4{beta}7-dependent adhesion by SDF-1{alpha} is not excluded, as this chemokine can influence {alpha}4{beta}1 affinity for VCAM-1 (55). We also show here that {alpha}4{beta}7/MAdCAM-1 interaction activates Rac1, which could contribute to the maintenance of enhanced lymphocyte adhesion and resistance to detachment.

The interaction of {alpha}4{beta}7 with MAdCAM-1 on Peyer’s patches and lamina propria HEV represents a key adhesion pathway in lymphocyte homing during recirculation (4). SDF-1{alpha} is expressed on most tissues, including secondary lymphoid tissues such as Peyer’s patches (31), and it has been proposed to be involved in lymphocyte recirculation (20, 31). SDF-1{alpha} displayed by HEV could bind to CXCR4 on lymphocytes, and our present data indicate that a functional consequence of this interaction is the up-regulation of {alpha}4{beta}7 adhesive activity, which might lead to lymphocyte adhesion strengthening to MAdCAM-1, representing a mechanism contributing to lymphocyte homing to secondary lymphoid tissues.

The CC chemokine secondary lymphoid tissue chemokine (SLC) (CXCL21) has also been reported to up-regulate {alpha}4{beta}7-dependent adhesion of human PBL and T cell lines to MAdCAM-1 in both static and flow chamber adhesion assays (51). It was found that SLC had a greater effect on naive than on memory CD4+ T cells, consistent with a preferential role of this chemokine for the homing of naive T cells, which has been further demonstrated with the use of plt mice that lack SLC expression (56, 57, 58). Both SDF-1{alpha} and SLC are probably involved in lymphocyte homing to secondary lymphoid tissues from the blood, but the present results together with SLC modulation of {alpha}4{beta}7-dependent lymphocyte adhesion suggest that SDF-1{alpha} might have a lesser role than SLC in defining the specificity of lymphocyte subset targeting.

{alpha}4{beta}7 binding to CS-1/FN might be important in gut-homing lymphocyte-matrix interactions within lymphoid tissues (4). In addition, {alpha}4{beta}7/FN interaction has been suggested to play important roles in lymphoma dissemination (59). Consequently, modulation of this adhesion by SDF-1{alpha} could contribute to lymphocyte trafficking in normal immune surveillance as well as in lymphoma invasion.

Further research directed at characterizing the mechanisms underlying chemokine-triggered modulation of {alpha}4{beta}7-dependent lymphocyte adhesion, including the study of G{alpha}i and G{alpha}13 involvement, is required for a better characterization of the molecular events implicated in lymphocyte homing during recirculation.


    Acknowledgments
 
We thank Drs. Francisco Sánchez-Madrid, Angel Corbí, M. Luisa Toribio, Alan Hall, Paul C. Sternweis, and John Collard for reagents. We also thank Drs. Francisco Sanz-Rodríguez and Jens Stein for their contribution to parts of this work, and Pedro Lastres for help with flow cytometry.


    Footnotes
 
1 This work was supported by Grant SAF99-0057 from Ministerio de Ciencia y Tecnología. N.W. is the recipient of a predoctoral fellowship from the Comunidad de Madrid. Back

2 Current address: Department of Hematology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029. Back

3 Address correspondence and reprint requests to Dr. Joaquin Teixidó, Department of Immunology, Centro de Investigaciones Biológicas, Velázquez 144, 28006 Madrid, Spain. E-mail address: joaquint{at}cib.csic.es Back

4 Abbreviations used in this paper: HEV, high endothelial venule; CS-1/FN, connecting segment-1 of fibronectin; F-actin, polymerized actin; PTX, pertussis toxin; SDF-1{alpha}, stromal cell-derived factor-1{alpha}; rh, recombinant human; MAdCAM-1, mucosal addressin cell adhesion molecule-1; sMAdCAM-1-IgG, soluble human MAdCAM-1-Ig fusion protein; CHO, Chinese hamster ovary; BCECF-AM, 2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethyl ester; SLC, secondary lymphoid tissue chemokine. Back

Received for publication July 12, 2001. Accepted for publication March 5, 2002.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Picker, L. J., E. C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561.[Medline]
  2. Mackay, C. R.. 1993. Homing of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:423.[Medline]
  3. Springer, T. A.. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.[Medline]
  4. Butcher, E. C., M. Williams, K. Youngman, L. Rott, M. J. Briskin. 1999. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72:209.[Medline]
  5. Holzmann, B., B. W. McIntyre, I. L. Weissman. 1989. Identification of a murine Peyer’s patch-specific lymphocyte homing receptor as an integrin molecule which an {alpha} chain homologous to human VLA-4{alpha}. Cell 56:37.[Medline]
  6. Erle, D. J., C. Rüegg, D. Sheppard, R. Pytela. 1991. Complete amino acid sequence of an integrin {beta} subunit ({beta}7) identified in leukocytes. J. Biol. Chem. 266:11009.[Abstract/Free Full Text]
  7. Yuan, Q., W.-M. Jiang, E. Leung, D. Hollander, J. D. Watson, G. W. Krissansen. 1992. Molecular cloning of the mouse integrin {beta}7 subunit. J. Biol. Chem. 267:7352.[Abstract/Free Full Text]
  8. Hu, M. C.-T., D. T. Crowe, I. L. Weissman, B. Holzmann. 1992. Cloning and expression of mouse integrin {beta}p({beta}7): a functional role in Peyer’s patch-specific lymphocyte homing. Proc. Natl. Acad. Sci. USA 89:8254.[Abstract/Free Full Text]
  9. Berlin, C., E. L. Berg, M. J. Briskin, D. P. Andrew, P. J. Kilshaw, B. Holzmann, I. L. Weissman, A. Hamann, E. C. Butcher. 1993. {alpha}4{beta}7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185.[Medline]
  10. Streeter, P. R., E. L. Berg, B. T. N. Rouse, R. F. Bargatze, E. C. Butcher. 1988. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature 331:41.[Medline]
  11. Schweighoffer, T., Y. Tanaka, M. Tidswell, D. J. Erle, K. J. Horgan, G. E. Ginther, A. I. Lazarovits, D. Buck, S. Shaw. 1993. Selective expression of integrin {alpha}4{beta}7 on a subset of human CD4+ memory T cells with hallmarks of gut-tropism. J. Immunol. 151:717.[Abstract]
  12. Rott, L. S., M. J. Briskin, D. P. Andrew, E. L. Berg, E. C. Butcher. 1996. A fundamental subdividision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. J. Immunol. 156:3727.[Abstract]
  13. Williams, M. B., E. C. Butcher. 1997. Selective homing of naive and memory T lymphocyte subsets to Peyer’s patches, lymph nodes and spleen. J. Immunol. 59:1746.
  14. Chan, B. M. C., M. J. Elices, E. Murphy, M. E. Hemler. 1992. Adhesion to vascular cell adhesion molecule 1 and fibronectin: comparison of {alpha}4{beta}1 (VLA-4) and {alpha}4{beta}7 on the human B cell line JY. J. Biol. Chem. 267:8366.[Abstract/Free Full Text]
  15. Rüegg, C., A. A. Postigo, E. E. Sikorski, E. C. Butcher, R. Pytela, D. J. Erle. 1992. Role of integrin {alpha}4{beta}7/{alpha}4{beta}P in lymphocyte adherence to fibronectin and VCAM-1 and homotypic cell clustering. J. Cell Biol. 117:179.[Abstract/Free Full Text]
  16. Ruiz-Velasco, N., M. Guerrero-Esteo, M. J. Briskin, J. Teixido. 2000. The {alpha}4 integrin subunit Tyr187 has a key role in {alpha}4{beta}7-dependent cell adhesion. J. Biol. Chem. 275:7052.[Abstract/Free Full Text]
  17. Higgins, J. M., M. Cernadas, K. Tan, A. Irie, J. Wang, Y. Takada, M. B. Brenner. 2000. The role of {alpha} and {beta} chains in ligand recognition by {beta}7 integrins. J. Biol. Chem. 275:25652.[Abstract/Free Full Text]
  18. Tidswell, M., R. Pachynski, S. W. Wu, S.-Q. Qiu, E. Dunham, N. Cochran, M. J. Briskin, P. J. Kilshaw, A. I. Lazarovits, D. P. Andrew, et al 1997. Structure-function analysis of the integrin {beta}7 subunit. J. Immunol. 159:1497.[Abstract]
  19. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, E. C. Butcher. 1995. {alpha}4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413.[Medline]
  20. Bleul, C. C., R. Fuhlbrigge, J. M. Casanovas, A. Aiuti, T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184:1101.[Abstract/Free Full Text]
  21. Bleul, C. C., J. L. Schultze, T. A. Springer. 1998. B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state and B cell receptor engagement. J. Exp. Med. 187:753.[Abstract/Free Full Text]
  22. D’Apuzzo, M., A. Rolink, M. Loetscher, J. A. Hoxie, I. Clark-Lewis, F. Melchers, M. Baggliolini, B. Moser. 1997. The chemokine SDF-1, stromal cell-derived factor-1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27:1788.[Medline]
  23. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829.[Medline]
  24. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, C. R. Mackay. 1997. The HIV receptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94:1925.[Abstract/Free Full Text]
  25. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J. L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J. M. Heard, I. Clark-Lewis, D. F. Legler, et al 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833.[Medline]
  26. Förster, R., E. Kremmer, A. Schubel, D. Breitfeld, A. Kleinschmidt, C. Nerl, Bernhardt G., M. Lipp. 1998. Intracellular and surface expression of the HIV-1 correceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J. Immunol. 160:1522.[Abstract/Free Full Text]
  27. Peled, A., V. Grabovsky, L. Habler, J. Sandbank, F. Arenzana-Seisdedos, I. Petit, H. Ben-Hur, T. Lapidot, R. Alon. 1999. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34+ cells on vascular endothelium under shear flow. J. Clin. Invest. 104:1199.[Medline]
  28. Hidalgo, A., F. Sanz-Rodríguez, J. L. Rodríguez-Fernández, R. Albella, C. Blaya, N. Wright, F. Prósper, C. Cabañas, J. C. Gutierrez-Ramos, J. Teixidó. 2001. The chemokine stromal cell-derived factor-1{alpha} modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells. Exp. Hematol. 29:345.[Medline]
  29. Sanz-Rodríguez, F., A. Hidalgo, J. Teixidó. 2001. Chemokine stromal cell-derived factor-1{alpha} modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood 97:346.[Abstract/Free Full Text]
  30. Grabovsky, V., S. Feigelson, C. Chen, D. A. Bleijs, A. Peled, G. Cinamon, F. Baleux, F. Arenzana-Seisdedos, T. Lapidot, I. van Kooyk, et al 2000. Subsecond induction of {alpha}4 clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J. Exp. Med. 192:495.[Abstract/Free Full Text]
  31. Nagasawa, T., K. Tachibana, K. Kawabata. 1999. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv. Immunol. 71:211.[Medline]
  32. Lazarovits, A. I., R. A. Moscicki, J. T. Kurnick, D. Camerini, A. K. Bhan, L. G. Baird, M. Erikson, R. B. Colvin. 1984. Lymphocyte activation antigens. I. Monoclonal Ab, anti-Act I, defines a new late lymphocyte activation antigen. J. Immunol. 133:1857.[Abstract]
  33. Vila-Coro, A., J. M. Rodriguez-Frade, A. Martin de Ana, M. C. Moreno-Ortiz, C. Martínez-A, M. Mellado. 1999. The chemokine SDF-1{alpha} triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 13:1699.[Abstract/Free Full Text]
  34. Mould, A. P., J. A. Askari, S. E. Craig, A. N. Garrat, J. Clements, M. J. Humphries. 1994. Integrin {alpha}4{beta}1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J. Biol. Chem. 269:27224.[Abstract/Free Full Text]
  35. Robledo, M. M., F. Sanz-Rodríguez, A. Hidalgo, J. Teixidó. 1998. Differential use of VLA-4 and VLA-5 integrins by hematopoietic precursors and myeloma cells to adhere to TGF-{beta}1-treated bone marrow stroma. J. Biol. Chem. 273:12056.[Abstract/Free Full Text]
  36. Nobes, C. D., A. Hall. 1995. Rho, rac and cdc42 regulate the assembly of multi-molecular focal complexes associated with actin stress fibers, lamellipodia and filopodia. Cell 81:53.[Medline]
  37. Robledo, M. M., R. A. Bartolomé, N. Longo, J. M. Rodríguez-Frade, M. Mellado, I. Longo, G. N. P. van Muijen, P. Sánchez-Mateos, J. Teixidó. 2001. Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem. 276:45098.[Abstract/Free Full Text]
  38. Sander, E. E., S. van Delft, J. P. ten Klooster, T. Reid, R. A. van der Kamen, F. Michiels, J. G. Collard. 1998. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J. Cell Biol. 143:1385.[Abstract/Free Full Text]
  39. Mellado, M., J. M. Rodriguez-Frade, A. M. Aragay, G. del Real, A. Vila-Coro, A. Martin de Ana, A. Serrano, Jr F. Mayor, C. Martínez-A. 1998. The chemokine MCP-1 triggers tyrosine phosphorylation of the CCR2B receptor and the JAK2/STAT3 pathway. J. Immunol. 161:805.[Abstract/Free Full Text]
  40. Fields, T. A., P. J. Casey. 1997. Signaling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem. J. 321:561.
  41. Hall, A.. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509.[Abstract/Free Full Text]
  42. Aktories, K., U. Braunn, S. Rosener, I. Just, A. Hall. 1989. The rho gene product expressed in E. coli is a substrate of botulinum ADP-ribosyltransferase C3. Biochem. Biophys. Res. Commun. 158:209.[Medline]
  43. Sallusto, F., D. Lenig, C. R. Mackay, A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875.[Abstract/Free Full Text]
  44. Erle, D. J., M. J. Briskin, E. C. Butcher, A. Garcia-Pardo, A. I. Lazarovits, M. Tidswell. 1994. Expression and function of the MAdCAM-1 receptor, integrin {alpha}4{beta}7, on human leukocytes. J. Immunol. 153:517.[Abstract]
  45. Kehrl, J. H.. 1998. Heterotrimeric G protein signaling: roles in immune function and fine-tuning by RGS proteins. Immunity 8:1.[Medline]
  46. Kozasa, T., X. Jiang, M. J. Hart, P. M. Sternweis, W. D. Singer, A. G. Gilman, G. Bollag, P. C. Sternweis. 1998. p115 RhoGEF, a GTPase activating protein for G{alpha}12 and G{alpha}13. Science 280:2074.[Free Full Text]
  47. Buhl, A. M., N. L. Johnson, N. Dhanasekaran, G. L. Johnson. 1995. G{alpha}12 and G{alpha}13 stimulate Rho-dependent stress fiber formation and focal adhesion assembly. J. Biol. Chem. 270:24631.[Abstract/Free Full Text]
  48. Fromm, C., O. A. Coso, S. Montaner, N. Xu, J. S. Gutkind. 1997. The small GTP-binding protein Rho links G protein-coupled receptors and G{alpha}12 to the serum response element and to cellular transformation. Proc. Natl. Acad. Sci. USA 94:10098.[Abstract/Free Full Text]
  49. Zhang, W. V., Y. Yang, R. W. Berg, E. Leung, G. W. Krissansen. 1999. The small GTP-binding proteins Rho and Rac induce T cell adhesion to the mucosal addressin MAdCAM-1 in a hierarchical fashion. Eur. J. Immunol. 29:2875.[Medline]
  50. Laudanna, C., J. J. Campbell, E. C. Butcher. 1997. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J. Biol. Chem. 272:24141.[Abstract/Free Full Text]
  51. Pachynski, R. K., S. W. Wu, M. D. Gunn, D. J. Erle. 1998. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin {alpha}4{beta}7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow. J. Immunol. 161:952.[Abstract/Free Full Text]
  52. Gerszten, R. E., E. A. García-Zepeda, Y.-C. Lim, M. Yoshida, H. A. Ding, Jr M. A. Gimbrone, A. D. Luster, F. W. Luscinskas, A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718.[Medline]
  53. Soede, R. D. M., I. S. Zeelenberg, Y. M. Wijnands, M. Kamp, E. Roos. 2001. Stromal cell-derived factor-1-induced LFA-1 activation during in vivo migration of T cell hybridoma cells requires Gq/11, RhoA, and myosin, as well as Gi and cdc42. J. Immunol. 166:4293.[Abstract/Free Full Text]
  54. D’Souza-Schorey, C., B. Boettner, L. Van Aelst. 1998. Rac regulates integrin-mediated spreading and increased adhesion of T lymphocytes. Mol. Cell. Biol. 18:3936.[Abstract/Free Full Text]
  55. Chan, J. R., S. J. Hyduk, M. I. Cybulsky. 2001. Chemoattractants induce a rapid and transient upregulation of monocyte {alpha}4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J. Exp. Med. 193:1149.[Abstract/Free Full Text]
  56. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451.[Abstract/Free Full Text]
  57. Mori, S., H. Nakano, K. Aritomi, C. R. Wang, M. D. Gunn, T. Kakiuchi. 2001. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193:207.[Abstract/Free Full Text]
  58. Vassileva, G., H. Soto, A. Zlotnik, H. Nakano, T. Kakiuchi, J. A. Hedrick, S. A. Lira. 1999. The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes. J. Exp. Med. 190:1183.[Abstract/Free Full Text]
  59. Yin, Z., E. Giacomello, E. Gabriele, L. Zardi, S. Aota, K. M. Yamada, B. Skerlavaji, R. Doliana, A. Colombatti, R. Perris. 1999. Cooperative activity of {alpha}4{beta}1 and {alpha}4{beta}7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain. Blood 93:1221.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
JEMHome page
M. Meiron, Y. Zohar, R. Anunu, G. Wildbaum, and N. Karin
CXCL12 (SDF-1{alpha}) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells
J. Exp. Med., October 27, 2008; 205(11): 2643 - 2655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Kerfoot, G. Andonegui, C. S. Bonder, and L. Liu
Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2524 - H2534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Miles, E. Liaskou, B. Eksteen, P. F. Lalor, and D. H. Adams
CCL25 and CCL28 promote {alpha}4{beta}7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow
Am J Physiol Gastrointest Liver Physiol, May 1, 2008; 294(5): G1257 - G1267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Bastianutto, A. Mian, J. Symes, J. Mocanu, N. Alajez, G. Sleep, W. Shi, A. Keating, M. Crump, M. Gospodarowicz, et al.
Local Radiotherapy Induces Homing of Hematopoietic Stem Cells to the Irradiated Bone Marrow
Cancer Res., November 1, 2007; 67(21): 10112 - 10116.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Garcia-Bernal, E. Sotillo-Mallo, C. Nombela-Arrieta, R. Samaniego, Y. Fukui, J. V. Stein, and J. Teixido
DOCK2 is Required for Chemokine-Promoted Human T Lymphocyte Adhesion Under Shear Stress Mediated by the Integrin {alpha}4beta1
J. Immunol., October 15, 2006; 177(8): 5215 - 5225.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. D. Gallego, M. A. de la Fuente, I. M. Anton, S. Snapper, R. Fuhlbrigge, and R. S. Geha
WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1{alpha}
Int. Immunol., February 1, 2006; 18(2): 221 - 232.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Vianello, P. Kraft, Y. T. Mok, W. K. Hart, N. White, and M. C. Poznansky
A CXCR4-Dependent Chemorepellent Signal Contributes to the Emigration of Mature Single-Positive CD4 Cells from the Fetal Thymus
J. Immunol., October 15, 2005; 175(8): 5115 - 5125.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Smaniotto, V. de Mello-Coelho, D. M. S. Villa-Verde, J.-M. Pleau, M.-C. Postel-Vinay, M. Dardenne, and W. Savino
Growth Hormone Modulates Thymocyte Development in Vivo through a Combined Action of Laminin and CXC Chemokine Ligand 12
Endocrinology, July 1, 2005; 146(7): 3005 - 3017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Garcia-Bernal, N. Wright, E. Sotillo-Mallo, C. Nombela-Arrieta, J. V. Stein, X. R. Bustelo, and J. Teixido
Vav1 and Rac Control Chemokine-promoted T Lymphocyte Adhesion Mediated by the Integrin {alpha}4{beta}1
Mol. Biol. Cell, July 1, 2005; 16(7): 3223 - 3235.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sela, R. Hershkoviz, L. Cahalon, O. Lider, and E. Mozes
Down-Regulation of Stromal Cell-Derived Factor-1{alpha}-Induced T Cell Chemotaxis by a Peptide Based on the Complementarity-Determining Region 1 of an Anti-DNA Autoantibody via Up-Regulation of TGF-{beta} Secretion
J. Immunol., January 1, 2005; 174(1): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Katayama, A. Hidalgo, A. Peired, and P. S. Frenette
Integrin {alpha}4{beta}7 and its counterreceptor MAdCAM-1 contribute to hematopoietic progenitor recruitment into bone marrow following transplantation
Blood, October 1, 2004; 104(7): 2020 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Heidemann, H. Ogawa, P. Rafiee, N. Lugering, C. Maaser, W. Domschke, D. G. Binion, and M. B. Dwinell
Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells
Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G1059 - G1068.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Bartolome, B. G. Galvez, N. Longo, F. Baleux, G. N. P. van Muijen, P. Sanchez-Mateos, A. G. Arroyo, and J. Teixido
Stromal Cell-Derived Factor-1{alpha} Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities
Cancer Res., April 1, 2004; 64(7): 2534 - 2543.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Lindholm, A. Naylor, E.-L. Johansson, and M. Quiding-Jarbrink
Mucosal Vaccination Increases Endothelial Expression of Mucosal Addressin Cell Adhesion Molecule 1 in the Human Gastrointestinal Tract
Infect. Immun., February 1, 2004; 72(2): 1004 - 1009.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Wright, T. L. de Lera, C. Garcia-Moruja, R. Lillo, F. Garcia-Sanchez, A. Caruz, and J. Teixido
Transforming growth factor-{beta}1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion
Blood, September 15, 2003; 102(6): 1978 - 1984.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. A. Bartolome, F. Sanz-Rodriguez, M. M. Robledo, A. Hidalgo, and J. Teixido
Rapid Up-Regulation of alpha 4 Integrin-mediated Leukocyte Adhesion by Transforming Growth Factor-beta 1
Mol. Biol. Cell, January 1, 2003; 14(1): 54 - 66.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Wilson, J. F. Hedges, E. C. Butcher, M. Briskin, and M. A. Jutila
Bovine {gamma}{delta} T Cell Subsets Express Distinct Patterns of Chemokine Responsiveness and Adhesion Molecules: A Mechanism for Tissue-Specific {gamma}{delta} T Cell Subset Accumulation
J. Immunol., November 1, 2002; 169(9): 4970 - 4975.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, N.
Right arrow Articles by Teixidó, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, N.
Right arrow Articles by Teixidó, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS